republic-os/legislation/us/states/co/2026a/sb-31.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Use of Prescription Product with Controlled Substance	The act exempts from schedule I a prescription drug product containing a schedule I controlled substance (product) if the product is:Approved for prescription use by the United States food and drug administration;Designated or rescheduled by the United States drug enforcement agency (DEA); Dispensed by a pharmacy or prescription drug outlet, or administered by an authorized practitioner; andPossessed by a person who is authorized to possess a controlled substance. The exemption applies upon the DEA's designation or rescheduling. The act requires that the product be controlled in Colorado in the same manner as the product is controlled by the DEA and state law. The act clarifies that its provisions do not apply to or affect the regulation of or lawful actions or conduct concerning natural medicine, natural medicine product, marijuana, or marijuana concentrate.(Note: This summary applies to this bill as enacted.)	us/states/co	Colorado General Assembly	2026A	SB 31	Colorado SB 31 (2026A)	bill	Crimes Corrections & Enforcement	enacted	J. Rich M. Soper S. Camacho W. Lindstedt	7	16	8	2026-01-22	2026-04-20	openstates	ocd-bill/83241539-e461-496e-85cc-596d70b0ea98	https://leg.colorado.gov/bills/SB26-031	25b78da87e685a3541a8c67be620279ae3dfd5e6075c62d3751882a6f4c4d29f	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-co

Colorado SB 31 (2026A) — Use of Prescription Product with Controlled Substance

The act exempts from schedule I a prescription drug product containing a schedule I controlled substance (product) if the product is:Approved for prescription use by the United States food and drug administration;Designated or rescheduled by the United States drug enforcement agency (DEA); Dispensed by a pharmacy or prescription drug outlet, or administered by an authorized practitioner; andPossessed by a person who is authorized to possess a controlled substance. The exemption applies upon the DEA's designation or rescheduling. The act requires that the product be controlled in Colorado in the same manner as the product is controlled by the DEA and state law. The act clarifies that its provisions do not apply to or affect the regulation of or lawful actions or conduct concerning natural medicine, natural medicine product, marijuana, or marijuana concentrate.(Note: This summary applies to this bill as enacted.)

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Introduced (filed) — source
2. Engrossed (committee substitute) — source
3. Final Act (committee substitute) — source
4. Reengrossed (committee substitute) — source
5. Rerevised (committee substitute) — source
6. Revised (committee substitute) — source
7. Signed Act (committee substitute) — source

Votes

• Adopt amendment L.001 (Attachment A). — pass (pass) · upper
• REPASS — pass (pass) · lower
• BILL — pass (pass) · lower
• Adopt amendment L.003 (Attachment C). — pass (pass) · upper
• Refer Senate Bill 26-031, as amended, to the Committee of the Whole. — pass (pass) · upper
• Adopt amendment L.004 (Attachment D). — pass (pass) · upper
• Refer Senate Bill 26-031, as amended, to the Committee of the Whole. — pass (pass) · upper
• CONCUR — pass (pass) · lower

Sponsors

• J. Rich — primary (person)
• M. Soper — primary (person)
• S. Camacho — primary (person)
• W. Lindstedt — primary (person)
• A. Boesenecker — cosponsor (person)
• B. Bradley — cosponsor (person)
• G. Rydin — cosponsor (person)
• J. Bacon — cosponsor (person)
• J. Bridges — cosponsor (person)
• J. Coleman — cosponsor (person)
• K. Brown — cosponsor (person)
• K. Nguyen — cosponsor (person)
• M. Duran — cosponsor (person)
• M. Rutinel — cosponsor (person)
• N. Hinrichsen — cosponsor (person)
• R. Stewart — cosponsor (person)
• S. Lieder — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2026-04-20 Governor Signed executive-signature
• 2026-04-08 Sent to the Governor executive-receipt
• 2026-04-07 Signed by the Speaker of the House passage
• 2026-04-07 Signed by the President of the Senate passage
• 2026-04-06 Senate Considered House Amendments - Result was to Concur - Repass
• 2026-04-02 House Third Reading Passed - No Amendments passage, reading-3
• 2026-03-31 House Third Reading Laid Over Daily - No Amendments
• 2026-03-30 House Second Reading Special Order - Passed with Amendments - Committee
• 2026-03-25 House Committee on Health & Human Services Refer Amended to House Committee of the Whole committee-passage, referral-committee
• 2026-02-25 Introduced In House - Assigned to Health & Human Services introduction
• 2026-02-24 Senate Third Reading Passed - No Amendments passage, reading-3
• 2026-02-23 Senate Second Reading Passed with Amendments - Committee, Floor reading-2
• 2026-02-18 Senate Second Reading Laid Over to 02/23/2026 - No Amendments
• 2026-02-12 Senate Committee on Health & Human Services Refer Amended to Senate Committee of the Whole committee-passage, referral-committee
• 2026-02-04 Senate Committee on Health & Human Services Witness Testimony and/or Committee Discussion Only
• 2026-01-22 Introduced In Senate - Assigned to Health & Human Services introduction

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/83241539-e461-496e-85cc-596d70b0ea98. Confidence: reported (aggregated from official Colorado legislature records).